DINA LEMKOVA-SERYY: Open Payments
NPI 1376981977 · FOREST HILLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,240 in 123 payments from 28 companies in 2025. Trend: 2023 $838 · 2024 $2,196 · 2025 $2,240
Food & beverage: $2,231Education: $9
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $388 |
| E.R. Squibb & Sons, L.L.C. | 19 | $202 |
| Amgen Inc. | 9 | $171 |
| Merck Sharp & Dohme LLC | 9 | $155 |
| SCPHARMACEUTICALS INC. | 7 | $153 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $147 |
| AstraZeneca Pharmaceuticals LP | 6 | $134 |
| HEARTFLOW, INC. | 5 | $105 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| Lilly USA, LLC | 4 | $94 |
Products named: LEQVIO, REPATHA, CAMZYOS, FUROSCIX, JARDIANCE, VERQUVO, AIRSUPRA, FFRct.
Industry payments across NY — which companies pay providers there.
